| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $23.0M | +6.3% |
| SG&A Expense | $9.7M | +2248.1% |
| Operating Income | -$32.7M | -5318.9% |
| Income Tax | $0 | -100.0% |
| Net Income | -$32.1M | -6525.0% |
| EPS (Basic) | -$1.62 | -1.3% |
| EPS (Diluted) | -$1.62 | -1.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.8M | +6708.4% |
| Short-term Investments | $2.0M | -84.5% |
| Current Assets | $21.2M | +9081.4% |
| Total Assets | $22.9M | -60.8% |
| Current Liabilities | $16.5M | +8719.9% |
| Total Liabilities | $16.5M | +6871.5% |
| Stockholders' Equity | $6.4M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.7M | -6697.6% |
| Capital Expenditures | $57K | +5.6% |
| Investing Cash Flow | $11.0M | +118.9% |
| Financing Cash Flow | $11.1M | -81.1% |
| Free Cash Flow | -$30.8M | -5982.8% |